2014
Trends in Use of Ezetimibe After the ENHANCE Trial, 2007 Through 2010
Ross JS, Frazee SG, Garavaglia SB, Levin R, Novshadian H, Jackevicius CA, Stettin G, Krumholz HM. Trends in Use of Ezetimibe After the ENHANCE Trial, 2007 Through 2010. JAMA Internal Medicine 2014, 174: 1486-1493. PMID: 25070672, PMCID: PMC4208827, DOI: 10.1001/jamainternmed.2014.3404.Peer-Reviewed Original ResearchConceptsLipid-lowering agentsENHANCE trialEzetimibe useEzetimibe initiationPharmacy benefit managersUse of ezetimibeProgression of atherosclerosisAdults 18 yearsHalf of adultsAtherosclerosis regression trialsPredictors of useBenefit managersEzetimibe monotherapyMonotherapy usersMedication initiationEligible adultsPrescription claimsCholesterol levelsRetrospective analysisMAIN OUTCOMEAdult beneficiariesUS census divisionsDiscontinuationRegression trialsEzetimibe
2006
Driving Times and Distances to Hospitals With Percutaneous Coronary Intervention in the United States
Nallamothu BK, Bates ER, Wang Y, Bradley EH, Krumholz HM. Driving Times and Distances to Hospitals With Percutaneous Coronary Intervention in the United States. Circulation 2006, 113: 1189-1195. PMID: 16520425, DOI: 10.1161/circulationaha.105.596346.Peer-Reviewed Original ResearchConceptsNon-PCI hospitalsPercutaneous coronary interventionST-elevation myocardial infarctionPCI hospitalsAdult populationCoronary interventionPrehospital triage protocolsAdults 18 yearsCross-sectional studyAmerican Hospital Association Annual SurveyHospital-level dataMedian timeMyocardial infarctionDirect referralTriage protocolHospitalTimely accessPatientsUnited StatesMinutesCensus tract-level dataInterventionTract-level dataTransport timePopulation